CA2326760A1 - Utilisation de l-glu-l-trp pour le traitement d'une infection par vih - Google Patents

Utilisation de l-glu-l-trp pour le traitement d'une infection par vih Download PDF

Info

Publication number
CA2326760A1
CA2326760A1 CA002326760A CA2326760A CA2326760A1 CA 2326760 A1 CA2326760 A1 CA 2326760A1 CA 002326760 A CA002326760 A CA 002326760A CA 2326760 A CA2326760 A CA 2326760A CA 2326760 A1 CA2326760 A1 CA 2326760A1
Authority
CA
Canada
Prior art keywords
trp
xaa
glu
compound
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002326760A
Other languages
English (en)
Inventor
Lawrence R. Green
Nickolay V. Sinackevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTRAN Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2326760A1 publication Critical patent/CA2326760A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des méthodes de traitement d'une infection par VIH par administration de quantités effectives de L-Xaa-L-TRP, Xaa représentant Glu, Ile ou Leu, ainsi que de leurs dérivés et analogues.
CA002326760A 1998-04-03 1999-04-02 Utilisation de l-glu-l-trp pour le traitement d'une infection par vih Abandoned CA2326760A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5509298A 1998-04-03 1998-04-03
US09/055,092 1998-04-03
PCT/US1999/007297 WO1999051256A2 (fr) 1998-04-03 1999-04-02 Utilisation de l-glu-l-trp pour le traitement d'une infection par vih

Publications (1)

Publication Number Publication Date
CA2326760A1 true CA2326760A1 (fr) 1999-10-14

Family

ID=21995541

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326760A Abandoned CA2326760A1 (fr) 1998-04-03 1999-04-02 Utilisation de l-glu-l-trp pour le traitement d'une infection par vih

Country Status (4)

Country Link
EP (1) EP1067951A2 (fr)
AU (1) AU3466799A (fr)
CA (1) CA2326760A1 (fr)
WO (1) WO1999051256A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774959C (fr) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Methode d'utilisation de dicetopiperazines et composition contenant ces substances
CN103191409A (zh) * 2003-05-15 2013-07-10 Dmi生物科学公司 T-细胞介导的疾病的治疗
US8217047B2 (en) 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
CA2810844C (fr) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Compositions de diketopiperazine destinees au traitement de syndrome metabolique et de troubles associes
CN104958752B (zh) 2011-10-10 2019-01-18 安皮奥制药股份有限公司 退行性关节病的治疗
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
JP6231484B2 (ja) 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
KR20170045274A (ko) 2014-08-18 2017-04-26 앰피오 파마슈티컬스 인코퍼레이티드 관절 징후의 치료
EP3310375A4 (fr) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies
US11027287B2 (en) * 2018-07-30 2021-06-08 Metso Minerals Industries, Inc. Gyratory crusher including a variable speed drive and control system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) * 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
IT1237474B (it) * 1989-10-05 1993-06-07 Polifarma Spa Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
WO1994020063A2 (fr) * 1993-03-04 1994-09-15 Cytoven International N.V. Tryptophane pharmaceutique contenant des compositions dipeptidiques et modes d'utilisation

Also Published As

Publication number Publication date
AU3466799A (en) 1999-10-25
WO1999051256A3 (fr) 1999-12-09
WO1999051256A2 (fr) 1999-10-14
EP1067951A2 (fr) 2001-01-17

Similar Documents

Publication Publication Date Title
KR101159477B1 (ko) 남용 방지성 암페타민 화합물
US7375082B2 (en) Abuse-resistant hydrocodone compounds
Chattopadhyay et al. Hepatoprotective Activity Of Oclmum Sanctum Leaf Extract Against Paracetamol Induced Hepatic Damage In Rats
JP4930055B2 (ja) 抗腫瘍剤
US7338939B2 (en) Abuse-resistant hydrocodone compounds
US6617310B2 (en) Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
AU2001251165A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
KR20060102556A (ko) 과용 또는 남용을 예방하기 위한 제약 조성물
JPH0150684B2 (fr)
CA2326760A1 (fr) Utilisation de l-glu-l-trp pour le traitement d'une infection par vih
JP2009533443A (ja) 一置換及び二置換のオキシコドン化合物及び組成物
US6060452A (en) Analogs of L-Glu-L-Trp having pharmacological activity
US11154587B2 (en) Use of peptides to stimulate the immune system
JP2004508311A (ja) 頭痛、片頭痛、悪心及び嘔吐用の医薬組成物
AU2004233587A1 (en) Use of a topical medicament comprising Riluzole
WO2009115634A1 (fr) Combinaisons synergiques de 5'-méthylthioadénosine
ES2231814T3 (es) Efectos metabolicos de ciertos analogos de glutation.
JP2006511538A (ja) 非ヌクレオシド系逆転写酵素阻害剤（ｎｎｒｔｉ）とプロテアーゼ阻害剤などのシトクロムｐ４５０の阻害剤とを含む組み合わせの使用
JPH09503776A (ja) 医療に使用する化合物
Gupta et al. Intermittent short duration therapy with fluconazole is effective for tinea capitis
US6649644B1 (en) Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor
NO332773B1 (no) Anvendelse av epotilon B og farmasoytisk preparat inneholdende en slik forbindelse
JP2008297208A (ja) アンジオテンシンｉ変換酵素阻害剤
JP2012158603A (ja) 耐糖能異常用医薬組成物及び飲食品
US3708593A (en) Use of l-prolyl l-leucyl glycine amide as an anti-depressant

Legal Events

Date Code Title Description
FZDE Discontinued